CH Biotech R&D Co., Ltd. (6534.TW)

TWD 80.6

(-0.49%)

Net Debt Summary of CH Biotech R&D Co., Ltd.

  • CH Biotech R&D Co., Ltd.'s latest annual net debt in 2023 was -94.76 Million TWD , down -125.97% from previous year.
  • CH Biotech R&D Co., Ltd.'s latest quarterly net debt in 2024 Q2 was -35.26 Million TWD , down -619.47% from previous quarter.
  • CH Biotech R&D Co., Ltd. reported annual net debt of 364.86 Million TWD in 2022, down -54.46% from previous year.
  • CH Biotech R&D Co., Ltd. reported annual net debt of 801.26 Million TWD in 2021, down -18.09% from previous year.
  • CH Biotech R&D Co., Ltd. reported quarterly net debt of -35.26 Million TWD for 2024 Q2, down -619.47% from previous quarter.
  • CH Biotech R&D Co., Ltd. reported quarterly net debt of 98.35 Million TWD for 2023 Q3, down -22.34% from previous quarter.

Annual Net Debt Chart of CH Biotech R&D Co., Ltd. (2023 - 2019)

Historical Annual Net Debt of CH Biotech R&D Co., Ltd. (2023 - 2019)

Year Net Debt Net Debt Growth
2023 -94.76 Million TWD -125.97%
2022 364.86 Million TWD -54.46%
2021 801.26 Million TWD -18.09%
2020 978.22 Million TWD 236.9%
2019 -714.54 Million TWD 0.0%

Peer Net Debt Comparison of CH Biotech R&D Co., Ltd.

Name Net Debt Net Debt Difference
Sinon Corporation -38.98 Million TWD -143.091%
Taiwan Fertilizer Co., Ltd. -4.2 Billion TWD 97.745%
All Cosmos Bio-Tech Holding Corporation -1 Billion TWD 90.54%